- Investopedia•2 days ago
Eagle Pharma bolsters the intellectual property portfolio for its cancer drug Bendeka.
- Insider Monkey•2 days ago
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is combined with progestin/estrogen. This now brings Teva’s oral contraceptive portfolio to over 50, ensuring that approximately 50% of prescriptions for oral contraceptives in the United States are a product of the global pharmaceutical firm that is […]
- Zacks•3 days ago
London based AstraZeneca plc (AZN) received a second Complete Response Letter (CRL) from the FDA for its new drug application (NDA) for investigational drug ZS-9.
TEVA : Summary for Teva Pharmaceutical Industries - Yahoo Finance
Teva Pharmaceutical Industries Limited (TEVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||32.16 - 32.68|
|52 Week Range||31.90 - 58.16|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||465.86|
|Dividend & Yield||1.36 (4.05%)|
|1y Target Est||N/A|